Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study

Title:	Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study
Authors:	Xu, Xiaojing^{Aff1, Aff2}; Ai, Luoyan^{Aff1, Aff2}; Hu, Keshu^{Aff1, Aff2}; Liang, Li^{Aff1, Aff2}; Lv, Minzhi^Aff2; Wang, Yan^{Aff1, Aff2}; Cui, Yuehong^{Aff1, Aff2}; Li, Wei^{Aff1, Aff2}; Li, Qian^{Aff1, Aff2}; Yu, Shan^{Aff1, Aff2}; Feng, Yi^{Aff1, Aff2}; Liu, Qing^{Aff1, Aff2}; Yang, Ying^Aff3; Zhang, Jiao^Aff3; Xu, Fei^Aff3; Yu, Yiyi^{Aff1, Aff2, IDs4146702451536x_cor16}; Liu, Tianshu^{Aff1, Aff2, Aff4, IDs4146702451536x_cor17}
Source:	Nature Communications. 15(1)
Database:	Springer Nature Journals